Axon Seminar Cell-based Therapies Wednesday 18 April 2012

The seminar addressed current and future EU legal and regulatory developments relevant to cell-based therapies. In particular, the seminar focused on how to choose and support the right regulatory pathway for a product and seeing that through on a multinational basis.

Speakers and their presentations:

Eliane Schutte, Signifix: Advanced Therapy Medicinal Products;

Carine van den Brink, Axon Lawyers: Latest Developments in Biotech Patents;

Alex Denoon, Denoon Legal & Erik Vollebregt, Axon Lawyers: Cell Based Therapies Legal & Regulatory

Navigate through our knowledgebase

Related articles


A case of so-called fiscal neutrality

Sometimes you come across cases that violate Mandalorian Creed: “One does not speak unless one knows.”. This happened to me last week when I read the Dutch Supreme Court’s judgment in a…

Read more


Can we fix / improve the MDR and the IVDR?

Or in other words that I’ve asked on this blog before: can the maker repair what he makes? This blog will argue that he can and he should. It still happens to…

Read more


MDR and IVDR amendment has entered into force now

Today is the day that the amendment, aka the ‘extension’, to the MDR enters into force because it was published in the EU’s Official Journal today, number L080. As you are reading this,…

Read more